Metabolic alkalosis and hypermagnesemia following "non-absorbable" antacid therapy.
D000471:Alkalosis / Q000139:chemically induced*; D000536:Aluminum Hydroxide / Q000009:adverse effects*; D004338:Drug Combinations / Q000009:adverse effects; D006801:Humans; D008274:Magnesium / Q000009:adverse effects* / Q000097:blood*; D008276:Magnesium Hydroxide / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D012828:Silicones / Q000009:adverse effects*; D012841:Simethicone / Q000009:adverse effects*
D004338:Drug Combinations; D012828:Silicones; C008570:aluminum hydroxide, magnesium hydroxide, simethicone drug combination; C013591:aluminum hydroxide, magnesium hydroxide, drug combination; D000536:Aluminum Hydroxide; D012841:Simethicone; D008274:Magnesium; D008276:Magnesium Hydroxide